{
    "code": "10000928",
    "time": "2015-07-24 03:54:56",
    "許可證字號": "衛署菌疫輸字第000928號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "106\/06\/19",
    "發證日期": "101\/06\/19",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000092805",
    "中文品名": "莫須瘤注射劑(德國廠)",
    "英文品名": "Mabthera solution for Infusion",
    "適應症": "非何杰金氏淋巴瘤：用於復發或對化學療法有抗性之低惡度B-細胞非何杰金氏淋巴瘤。併用CVP化學療法用於未經治療之和緩性(組織型態為濾泡型)B細胞非何杰金氏淋巴瘤的病人。併用CHOP或其他化學療法用於CD20抗原陽性之瀰漫性大型B細胞非何杰金氏淋巴瘤。用於做為濾泡性淋巴瘤患者對誘導療法產生反應之後的維持治療用藥。\r\n類風濕性關節炎：與methotrexate併用，適用於治療曾接受一種(含)以上之腫瘤壞死因子(TNF)抑制療法治療但效果不彰，或無法耐受的活動性類風濕性關節炎成人患者。莫須瘤(MabThera)與methotrexate併用，經X光檢查已證實可減緩關節結構受損的進展。\r\n慢性淋巴球性白血病：莫須瘤(MabThera)適用於與fludarabine及cyclophosphamide併用，做為CD20陽性慢性淋巴球性白血病(CLL)患者的第一線用藥。莫須瘤(MabThera)適用於與化學療法併用，做為復發\/頑固性的CD20陽性慢性淋巴球性白血病病患的治療用藥。\r\n「肉芽腫性血管炎(Granulomatosis with Polyangiitis,GPA)(Wegener’s 肉芽腫症)及顯微多發性血管炎(Microscopic Polyangiitis ,MPA)：莫須瘤(MabThera)與葡萄糖皮質素(glucocorticoids)併用，適用於治療成人之肉芽腫性血管炎(GPA，亦稱為韋格納肉芽腫症)及顯微多發性血管炎(MPA)。",
    "劑型": "270注射劑",
    "包裝": "每小瓶10毫升、50毫升裝，100小瓶以下盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "Rituximab",
    "限制項目": [
        ""
    ],
    "申請商名稱": "1901701100  羅氏大藥廠股份有限公司",
    "申請商地址": "台北市松山區民生東路三段１３４號９樓",
    "主製造廠": {
        "製造廠名稱": "F470261000  ROCHE DIAGNOSTICS GMBH",
        "製造廠廠址": "SANDHOFERSTRASSE 116, D-68305, MANNHEIM, GERMANY",
        "製造廠公司地址": "",
        "製造廠國別": "GERMANY",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F430208000  F.HOFFMANN-LA ROCHE LTD.",
            "製造廠廠址": "WURMISWEG, CH-4303, KAISERAUGST, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "F460767000  GENENTECH, INC.",
            "製造廠廠址": "1000 NEW HORIZONS WAY, VACAVILLE, CA 95688, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        },
        {
            "製造廠名稱": "F460768000  GENENTECH, INC.",
            "製造廠廠址": "1 ANTIBODY WAY, OCEANSIDE, CA 92056, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013002400",
            "成分名稱": "Rituximab",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 100009280001-104-07-06.pdf 100009280001-104-02-01.pdf 20131213_Response_2_A2_100009280001-103-01-10.pdf 100009280001___20120912.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=10000928&Seq=004&Type=9"
        },
        {
            "title": "外盒 100009280005___20120912.pdf 100009280004___20120912.pdf 100009280003___20120912.pdf 100009280002___20120912.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=10000928&Seq=004&Type=8"
        }
    ]
}